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To determine the differential effects of genetic polymorphism in CFH and ARMS2 on risk of
age-related macular degeneration (AMD) between phakic vs. pseudophakic/aphakic eyes.
Methods
9,529 eyes of 4,918 participants from the Singapore Malay Eye Study and Singapore Indian
Eye Study were analyzed. Participants had detailed eye examinations, including slit-lamp
examinations and dilated fundus photography. AMD grading was performed according to
the Wisconsin age-related maculopathy grading system. Lens status was defined. Single
nucleotide polymorphisms (SNPs) rs10801555 (Y402H) within CFH and rs3750847 in
ARMS2 were assessed. The main outcome measure was early AMD or any AMD.
Results
No significant associations between the CFH Y402H genotypes and early AMD were
found in phakic individuals. In contrast, among pseudophakic/aphakic individuals, the CFH
Y402H risk genotypes were significantly associated with higher odds of early AMD, with
an OR of 1.57 (95% CI: 1.07–2.29) for GA genotype and 2.40 (95% CI: 1.25–4.61) for AA
genotype, compared to those with GG genotype. There was significant interaction between
pseudophakic/aphakic status and CFH Y402H variant on risk of early AMD (p = 0.037), ad-
justing for age, gender, and the first 5 genetic principal components. No significant interac-
tion was found between lens status and ARMS2 rs3750847.
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Conclusions
CFH genetic polymorphism and pseudophakic/aphakic status may have a potential syner-
gistic effect on early AMD, suggesting roles for the complement system and related path-
ways in the pathogenesis of AMD in eyes after cataract surgery.
Introduction
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in both
developed and developing countries [1–5]. AMD is a pathogenically complex disease, an out-
come of both multiple environmental and genetic factors. Much research has been undertaken
to examine individual environmental and genetic risk factors for early and late AMD [6–8].
Regarding genetic factors, the CFH Y402H on chromosome 1q32 was the first identified
AMD susceptibility variant [9–11]. Subsequently, ARMS2/HTRA1 on chromosome 10q26 was
also found to be associated with risk of AMD [12,13]. ARMS2 risk alleles were found to be pref-
erentially associated with risk of neovascular AMD while CFH risk alleles were more frequently
associated with risk of geographic atrophy [14,15]. A recent meta-analysis of genome-wide as-
sociation studies including>17,000 advanced AMD cases and>60,000 controls confirmed the
associations at CFH (odds ratio [OR] = 2.43) and ARMS2 (OR = 2.76) loci [16]. Other variants
associated with AMD have much smaller effect sizes, and include genes involved in comple-
ment system, cholesterol metabolism, and angiogenesis pathways [17]. In Asians, however, the
relationship and contribution of these genetic risk loci on AMD are less clear with fewer studies
available [18].
Besides smoking, cataract surgery is the most consistent “environmental” risk factor for
AMD observed in previous studies [7,19,20], including a meta-analysis of three prospective
studies in Caucasian populations [20–22]. In Asians, the relationship of cataract surgery and
AMD is again less clear. The Beijing Eye Study for example did not find an association of either
early or late AMD with cataract surgery in Chinese persons [23]. Furthermore, the exact mech-
anism for the increased risk of AMD after cataract surgery remains unknown and may involve
increased exposure to blue visible light [24,25] or a chronic foreign body inflammatory re-
sponse in the eye due to implantation of an intraocular lens [26].
Genetic interactions with environmental factors provide important insights into the under-
standing of the pathophysiology of AMD. We hypothesized that persons with the two major
genetic polymorphisms would have a higher risk of AMD and the risk was aggravated in eyes
with past cataract surgery. We therefore conducted this study to assess the independent associ-
ations of CFH and ARMS2 genetic polymorphisms and lens status (i.e., pseudophakic/aphakic
eyes) with AMD, and to investigate the gene-environment interaction between lens status and
genetic polymorphisms on the risk of this disease.
Methods
Study population
Our study population consisted of subjects from 2 population-based studies: the Singapore
Malay Eye Study (SiMES) (2004–2006) and the Singapore Indian Eye Study (2007–2009). The
detailed methodologies of these studies have been published elsewhere [27,28]. In brief, an age-
stratified random sampling was used to select ethnic Malays and Indians 40 to 80 years of age,
who were living in Singapore during each stipulated study period. These studies were
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conducted at the Singapore Eye Research Institute with approval from the Singhealth Institu-
tional Review Board. The study was conducted in accordance with the Declaration of Helsinki,
with written informed consent obtained from all subjects before participation.
Clinical examination
Standardized systemic and ocular examinations, interviewer-administered questionnaires, and
standard blood investigations were conducted on the same day for all participants.
A digital nonmydriatic retinal camera (Canon CR-DGi with a 10D SLR backing, Canon,
Japan) was used to obtain color photographs of Early Treatment for Diabetic Retinopathy
Study (ETDRS) standard field 1 (centered on the optic disc) and ETDRS standard field 2 (cen-
tered on the fovea) of each eye. The photographs were saved to hard disk, backed up on DVDs,
and sent for grading for the presence of AMD using the Wisconsin age-related maculopathy
grading system [29]. Standardized slit-lamp examinations (Haag-Streit model BQ-900; Haag-
Streit, Bern, Switzerland) were performed by trained study ophthalmologists after pupil dilata-
tion to determine lens status (phakic, pseudophakic or aphakic) and the fundus was examined
with a 78D lens.
A detailed interviewer-administered questionnaire was used to collect relevant sociodemo-
graphic data and medical history from all participants. Data such as education, occupation
(predominantly indoor or outdoor), lifestyle risk factors (e.g., smoking and alcohol intake),
and medical and surgical histories were collected. Blood pressure was measured with a digital
automatic blood pressure monitor (Dinamap model Pro Series DP110X-RW, 100V2; GEMedi-
cal Systems Information Technologies, Inc, Milwaukee, WI) after the participants were seated
for at least 5 minutes. Nonfasting venous blood samples were collected for biochemistry tests,
including serum lipids (total cholesterol, high-density lipoprotein cholesterol, low-density lipo-
protein cholesterol), glycosylated hemoglobin A1c, creatinine, and random glucose. All choles-
terol levels were analyzed in participants on a continuous scale. The average of the 2 systolic
and diastolic blood pressure measurements was used as the systolic and diastolic blood pres-
sure value. Hypertension was defined as systolic blood pressure of 140 mm Hg or more or dia-
stolic blood pressure of 90 mm Hg or more or self-reported physician-diagnosed hypertension.
Diabetes mellitus was defined as random glucose of 11.1 mmol/L or more, use of diabetic medi-
cation, or a physician diagnosis of diabetes mellitus. Hyperlipidemia was defined as a total cho-
lesterol level of 239.4 mg/dL or more (to convert to mmol/L multiply by 0.0259), or use of lipid
lowering medication. Chronic kidney disease was defined as an estimated glomerular filtration
rate of less than 60 mL/min per 1.73 m2 based on the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equations [30].
AMD grading
Photograph grading was performed in a standard manner according to the Wisconsin age-
related maculopathy grading system. The prevalence of AMD in SiMES and the Singapore In-
dian Eye Study was 7.7% and 5.7%, respectively [31,32]. Among the AMD features evaluated
were drusen size, type, and area; increased retinal pigment; retinal pigment epithelial depig-
mentation; pure geographic atrophy; and signs of exudative macular degeneration. Drusen
were classified as hard or soft; then soft drusen were divided into distinct and indistinct soft
drusen. Early AMD was defined by either any soft drusen (distinct or indistinct) and pigmen-
tary abnormalities or large soft drusen 125 μm or more in diameter with a large drusen area
(>500-μm-diameter circle) or large soft indistinct drusen in the absence of signs of late AMD.
Late AMD was defined by the presence of any of the following: geographic atrophy or pigment
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epithelial detachment, subretinal hemorrhage or a visible subretinal new vessel, or a subretinal
fibrous scar or laser treatment scar for AMD.
Genotyping
All samples were genotyped using Illumina Human610-Quad BeadChips (Illumina Inc.),
which assays 620,901 SNPs across the genome, according to manufacturer protocols. In brief,
quality control (QC) criteria included a first round for autosomes SNP QC to obtain a cleaned
set of genotypes for sample QC, by excluding SNPs with: (1) missingness (per SNP call rate)
>5%; (2) minor allele frequency (MAF)< 1%; and (3) Hardy Weinberg Equilibrium (HWE)
p-value<10−6. Using the subset of SNPs passing the first round QC, samples were then exclud-
ed based on the following conditions: (1) per-sample call rates of less than 95%; (2) excessive
heterozygosity (defined as the sample heterozygosity); (3) cryptic relatedness; (4) gender dis-
crepancies; and (5) deviation in population membership from population structure analysis. A
second round of SNP QC was then applied to the remaining samples passing quality checks.
We excluded SNPs with missingness>5%, gross departure from HWE (p<10−6) and
MAF<1%. The commonly associated SNPs in the CFH and ARMS2/HTRA-1 genes, namely
rs1061170 and rs10490924, were not included in the Human610-Quad BeadChips. Hence, we
proceeded to test other SNPs within the genes of interest i.e. CFH and ARMS2/HTRA-1 for as-
sociations with AMD as well as interaction effects with lens status on the association with
AMD. We chose the SNP rs10801555 for CFH and rs3750847 for ARMS2 after confirming
that they were in perfect linkage disequilibrium (LD; r2 = 1.0) with the Y402H variant
(rs1061170) for CFH and rs10490924 for ARMS2 [33]. In SiMES and SINDI, the MAF for
rs10801555 is 0.09 and 0.28, respectively, and the MAF for rs3750847 is 0.39 and 0.34,
respectively.
Statistical Analysis
Statistical analysis was performed with STATA version 12.0 (Texas, USA). A p value of<0.05
was considered statistically significant. Comparison of groups was performed with chi square
tests for categorical variables, and two sample t-tests for continuous variables. In multivariate
analysis of the main effect of pseudophakic/aphakic status, the OR (95% confidence interval
[CI]) of AMD presence was adjusted for potential risk factors, including age, gender, smoking
status, ethnicity, hypertension, diabetes, hyperlipidemia and chronic kidney disease. Data from
both eyes of the same individual were included in the analysis, and generalized estimating
equation (GEE) analysis [34] was used to account for correlation between eyes from the
same individual.
For gene-environmental (G x E) interaction, we performed a 1 df test for βGE using the GEE
model:
logit PðAMD ¼ 1jX;G;EÞ ¼ b0 þ bXXþ bGGþ bEEþ bGEGE
where X is a matrix of covariates as listed in the main effect model; G is the number of risk al-
lele for a SNP (rs10801555: A; rs3750847: T), coded as 0, 1 or 2; E is the environmental expo-
sure status, whether the individual had pseudophakic/aphakic eyes. The p-value of the
interaction term βGE GE was used to assess the signiﬁcance of the interaction between lens sta-
tus and genetic variants. Odds ratios and their 95% CIs were calculated per copy of risk allele,
assuming a log-additive increase for each risk allele. To control for population substructure in
our study population, we performed principal component (PC) analysis using the EIGEN-
STRAT software v4.2 [35], and the ﬁrst 5 PCs, were included as covariates in our regression
models.
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Results
There were 6,680 participants from SiMES and SINDI. 3,236 eyes were excluded as those par-
ticipants either were not genotyped or failed genotyping QC. A further 595 eyes were excluded
due to incomplete data for AMD and lens status. A total of 4,918 subjects with 9,529 eyes were
left and included in the study. Of these, 4,799 subjects have complete data on the following var-
iables: early AMD, any AMD, gender, smoking, age, hypertension, diabetes, hyperlipidaemia,
CKD, CFH rs10801555 and ARMS2 rs3750847. Table 1 shows the characteristics of subjects
without AMD, with early AMD and with any AMD. There were 4,626 subjects without AMD,
274 subjects with early AMD and 292 subjects with any AMD. AMD cases were more likely to
be older men, with hypertension, hyperlipidemia and chronic kidney disease (all p<0.05).
Similar results were obtained for any AMD cases.
Of the 9,529 eyes, 925 (9.7%) were either pseudophakic or aphakic (Table 2). More Indian
subjects were pseudophakic/aphakic than Malays (p<0.001). There were no differences in dis-
tribution of early or any AMD between Malays and Indians (Table 2).
Table 4 shows the assessment of each main effect in isolation (lens status or risk genotypes).
After adjusting for age, gender, ethnicity, smoking status, hypertension, diabetes, hyperlipid-
emia, chronic kidney disease, pseudophakic/aphakic eyes remained more likely to have early
AMD (OR = 1.36; 95% CI: 0.99–1.87) or any AMD (OR = 1.21, 95% CI: 0.89–1.66), although
these associations did not reach statistical significance (Model 2 in Table 4). Consistent with
the univariate analysis, the ARMS2 SNP was associated with early AMD in the models adjusted
for potential risk factors (Model 1, p = 0.002; Model 2, p = 0.001, Table 4) and any AMD
(Model 1, p = 0.001; Model 2, p<0.001, Table 4).
Table 1. Characteristics of subjects without AMD, with early AMD and with any AMD.
Demographics All (N = 4918)a Without AMD (N = 4626) With Early AMD (N = 274) With Any AMD (N = 292) P Valueb P Valuec
Age (yrs) 58.54 (10.45) 58.07 (10.28) 66.02 (10.31) 66.1 (10.27) <0.001 <0.001
Female 2441 (49.63) 2332 (50.41) 105 (38.32) 109 (37.33) <0.001 <0.001
Current smokers 872 (17.76) 828 (17.92) 39 (14.34) 44 (15.17) 0.133 0.235
Hypertension 3097 (63.23) 2863 (62.16) 217 (79.20) 234 (80.14) <0.001 <0.001
Diabetes 1395 (28.69) 1304 (28.51) 86 (31.73) 91 (31.49) 0.254 0.278
Hyperlipidaemia 2119 (43.63) 1976 (43.25) 134 (49.63) 143 (49.65) 0.040 0.034
Chronic kidney disease 761 (15.48) 688 (14.88) 69 (25.18) 73 (25.00) <0.001 <0.001
CFH rs10801555
GG 3333 (67.77) 3144 (67.96) 180 (65.59) 189 (64.73)
GA 1357 (27.59) 1276 (27.58) 75 (27.37) 81 (27.74) 0.160 0.049
AA 228 (4.64) 206 (4.45) 19 (6.93) 22 (7.53)
ARMS2 rs3750847
CC 1992 (40.50) 1885 (40.75) 103 (37.59) 107 (36.53)
CT 2257 (45.89) 2133 (46.11) 111 (40.51) 124 (42.47) <0.001 <0.001
TT 669 (13.60) 608 (13.14) 60 (21.90) 61 (20.89)
Data presented are no. (%), except for age, which is presented as mean (SD). Analysis was done by individual level.
a Number of subjects with missing data for the following variables: current smokers, 8; hypertension, 20; diabetes, 55; hyperlipidaemia, 61; chronic kidney
disease, 1.
b For comparison between individuals without AMD vs with early AMD, using chi-square tests for categorical variables, and two sample t-tests for
continuous variables.
c For comparison between individuals without AMD vs with any AMD, using chi-square tests for categorical variables, and two sample t-tests for
continuous variables.
doi:10.1371/journal.pone.0119570.t001
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Stratified analysis was performed for the phakic vs. pseudophakic/aphakic groups (Table 5),
adjusted for age, gender and the first 5 genetic principal components. In phakic eyes, the risk of
early AMD was similar in those with the CFH Y402H risk genotypes (genotype GA: OR = 0.95,
95% CI: 0.73–1.25; AA: OR = 0.91, 95% CI: 0.53–1.55), to those with GG genotype. In contrast,
pseudophakic/aphakic eyes that had the Y402H risk genotype were more likely to have early
AMD, OR 1.57 (95% CI: 1.07–2.29) for the GA genotype and OR 2.40 (95% CI: 1.25–4.61) for
the AA genotype, compared to those that had the GG genotype and were phakic (Fig. 1). The
interaction between pseudophakic/aphakic status and CFH Y402H on the risk of early AMD
was significant (p = 0.037). After additional adjustment for potential confounders, namely
smoking status, hypertension, diabetes, hyperlipidemia and chronic kidney disease, the interac-
tion remained significant (p = 0.045). A similar association trend was observed for any AMD
(Table 5), but the interaction did not reach statistical significance (p = 0.115). We performed
the same analysis with another CFH SNP rs379489 and obtained similar results (p for interac-
tion 0.015 for early AMD and 0.046 for any AMD). After removing aphakic eyes, the p value
for interaction between early AMD and CFH remained significant (0.042), with minimal
changes to OR or 95% CI. There was no significant difference in visual acuity between pseudo-
phakic patients with or without early/any AMD who have at least 1 CFH risk allele (p = 0.175,
data not shown).
For the ARMS2 genotype, compared to phakic eyes with the CC genotype, the risk of having
early AMD was higher both in pseudophakic/aphakic eyes (genotype CT: OR = 1.69, 95% CI:
Table 2. Distribution of AMD and cataract surgeries by ethnicity.
Total (N = 9529 Eyes) Malays (N = 4675 Eyes) Indians (N = 4854 Eyes) P Valuea
Early AMD 346 (3.63) 159 (3.41) 187 (3.86) 0.243
Late AMD 31 (0.33) 18 (0.40) 13 (0.28) 0.321
Any AMD 377 (3.96) 177 (3.79) 200 (4.12) 0.403
Past Cataract Surgery
Pseudophakic 916 (9.62) 329 (7.04) 587 (12.10)
Aphakic 9 (0.09) 5 (0.11) 4 (0.08)
Total 925 (9.71) 334 (7.14) 591 (12.18) <0.001
Data presented are no. (%). Analysis was done on eye level.
aP values are for 2x2 comparisons between variable of interest (yes/no) and ethnicity (malays/indians), 1 degree of freedom chi-square test.
Pseudophakic/aphakic eyes were more likely have early AMD (9.1%) or any AMD (9.3%), compared to phakic eyes (3.0% and 3.4% with early and any
AMD, respectively, both p <0.001, Table 3). In the univariate analysis, the ARMS2 (rs3750847) genotype was signiﬁcantly associated with early AMD and
any AMD (both p <0.001), while the CFH (rs10801555) genotype had marginally signiﬁcant association with any AMD (p = 0.049) but not with early AMD
(p = 0.160, Table 1).
doi:10.1371/journal.pone.0119570.t002
Table 3. Distribution of AMD by presence or absence of previous cataract surgery.
Pseudophakic/Aphakic Eyes (N = 925) Phakic Eyes (N = 8604) P Valuea
Early AMD 84 (9.1) 262 (3.0) <0.001
Any AMD 86 (9.3) 291 (3.4) <0.001
Data presented are no. (%). Analysis was done on eye level.
a P values are for 2x2 comparisons between pseudophakic/aphakic eyes vs. phakic eyes, 1 degree of
freedom chi-square test.
doi:10.1371/journal.pone.0119570.t003
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Table 5. Joint effects of lens status and CFH/ARMS2 SNP on risk of early AMD and any AMD.
Early AMD, ORa (95% CI) Any AMD, ORa (95% CI)
Phakic Eyes (N =
8,575)
Pseudophakic/Aphakic Eyes (N =
923)
Phakic Eyes (N =
8,604)
Pseudophakic/Aphakic Eyes (N =
925)
CFH rs10801555
GG [Reference] 1.02 (0.69–1.51) [Reference] 0.97 (0.66–1.42)
GA 0.95 (0.73–1.25) 1.57 (1.07–2.29)b 1.06 (0.82–1.36) 1.46 (1.00–2.12)





CC [Reference] 1.15 (0.72–1.82) [Reference] 1.05 (0.67–1.66)
CT 1.28 (1.04–1.57)b 1.69 (1.18–2.42)c 1.30 (1.07–1.58)c 1.53 (1.08–2.18)b




OR, odds ratio; CI, conﬁdence interval.




d P-value of the interaction term βGE GE was used to assess the signiﬁcance of the interaction between lens status and genetic variants.
doi:10.1371/journal.pone.0119570.t005
Table 4. Multivariate analysis showing the association of AMD with lens status, and the CFH and ARMS2 SNPs.
Early AMD Any AMD
Model 1a
(N = 9498)




OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Lens status
Phakic [Reference] [Reference] [Reference] [Reference]
Pseudophakic/Aphakic 1.29 (0.95–1.77) 0.108 1.36 (0.99–1.87) 0.058 1.16 (0.85–1.57) 0.349 1.21 (0.89–1.66) 0.225
CFH rs10801555
GG [Reference] [Reference] [Reference] [Reference]
GA 1.10 (0.88–1.37) 0.421 1.09 (0.86–1.37) 0.478 1.17 (0.94–1.45) 0.160 1.16 (0.93–1.44) 0.187
AA 1.20 (0.77–1.88) 1.18 (0.75–1.87) 1.36 (0.89–2.09) 1.34 (0.87–2.08)
ARMS2 rs3750847
CC [Reference] [Reference] [Reference] [Reference]
CT 1.32 (1.11–1.58) 0.002 1.37 (1.14–1.64) 0.001 1.33 (1.12–1.58) 0.001 1.37 (1.15–1.63) <0.001
TT 1.75 (1.23–2.51) 1.86 (1.30–2.68) 1.77 (1.25–2.50) 1.88 (1.32–2.67)
OR, odds ratio; CI, conﬁdence interval.
aMultivariate logistic regression using general estimating equations, adjusted for age, gender, and ethnicity for the effect of lens status, and additionally
adjusted for the ﬁrst 5 genetic principal components for the effects of SNPs.
bAdjusted for the covariates in Model 1 and current smoker, hypertension, diabetes, hyperlipidaemia, and chronic kidney disease.
doi:10.1371/journal.pone.0119570.t004
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1.18–2.42; TT: OR = 2.48, 95% CI: 1.44–4.27) and phakic eyes (genotype CT: OR = 1.28, 95%
CI: 1.04–1.57; TT: OR = 1.64, 95% CI: 1.09–2.46). There was no significant interaction between
lens status and the ARMS2 SNP for either early AMD (p = 0.495) or any AMD (p = 0.570).
Discussion
We identified a statistically significant interaction between lens status and the CFH gene poly-
morphism on the risk of early AMD, suggesting a possible synergistic effect between the two.
Pseudophakic/aphakic status was found to increase the risk of early AMD in patients with CFH
risk genotypes above the risk conferred by either factor alone.
There are few comparable studies. The Rotterdam Eye Study previously examined the inci-
dence of AMD in patients with prior cataract who were CFH Y402H carriers, and found that
the OR for dry AMD in CFH carriers after cataract surgery increased in an allele-dose manner
with an OR of 2.30 (95% CI: 0.28–18.83) for non-carriers, 3.31 (95% CI: 1.23–8.91) for hetero-
zygotes, and 4.02 (95% CI: 1.37–11.79) for homozygous CFH Y402H carriers [36]. Whether
this increased risk was entirely due to CFH genetic susceptibility or represented an interaction
effect was not explored. As far as we know, our study is the first to report a significant gene-en-
vironment interaction between CFH genetic polymorphism and lens status on the risk of
AMD.
Fig 1. Forest plot of joint effects of pseudophakic\aphakic status andCFH SNP on risk of early AMD.
doi:10.1371/journal.pone.0119570.g001
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Importantly, in our study neither pseudophakic/aphakic status nor the CFH risk genotype
alone had a significant association with AMD. An association was found only when both fac-
tors were present. This suggests an unmasking effect: genetic susceptibility leading to disease
being more prominent in the presence of an environmental trigger or another susceptibility
gene. This is exemplified in other conditions. For example, in phenylketonuria, a mutation in
the gene for a hepatic enzyme phenylalanine hydroxylase (genetic susceptibility) results in dis-
ease only in the presence of a diet consisting of the amino acid phenylalanine (environmental
trigger). In Alzheimer’s disease, BACE1 polymorphism (susceptibility gene) alone was not as-
sociated with disease, but in the presence of another gene, APOE epsilon 4 (genetic trigger), the
effect of BACE1 was revealed [37]. This effect may, in part, explain why risk factors for disease
appear to differ between populations. Genetic, environmental factors and their interactions dif-
fer between populations, some of which are unknown or unexplored, confounding the associa-
tions of known risk factors with AMD.
Our findings suggest that the complement pathway plays a role in the pathogenesis of AMD
in pseudophakic/aphakic eyes. At least two mechanisms have been postulated for how CFH
Y402H polymorphism may result in AMD. First, it may reduce binding of CRP to the CFH
protein, affecting its ability to inhibit complement pathway. Second, it may affect the binding
of CFH to cell surface glycosaminogycans (GAGs), thus limiting the function of CFH [38,39].
Cataract surgery with implantation of an intraocular lens (IOL) can cause inflammation in sev-
eral ways. Older studies on uveal biocompatibility of IOLs have found epithelioid and giant
cells on certain IOL materials, characteristics of a foreign body cell reaction [40–42]. Moreover,
surgical trauma during cataract operation compromises the blood ocular barrier [43] and
could expose the intraocular environment to circulating systemic mediators of inflammation.
Lastly, Pokidysheva has shown in vitro activation of complement by an older type of intraocu-
lar lens, although in vivo correlation has not been demonstrated in animals or humans [44].
We simultaneously assessed the interaction between ARMS2 and lens status on the risk of
early AMD. Animal studies have demonstrated the role of ARMS2 in the phagocytosis of pho-
toreceptor outer segments [45]. In aphakic eyes or pseudophakic eyes that were not implanted
with blue-light filtering (400–480nm) IOLs, the retina is exposed to UV light and blue visible
light that would otherwise have been absorbed by the crystalline lens [46]. A possible effect of
this exposure is an increase in generation of reactive oxygen species, which, coupled with lipo-
fuscin accumulation from impaired RPE phagocytosis, may lead to eventual RPE cell death
[24,47–49]. In our study, although the ARMS2 SNP is associated with early AMD, lens status
and the ARMS2 genotypes did not have a significant synergistic effect. However, we observed
that the ORs of having early AMD or any AMD were in general higher in pseudophakic/
aphakic individuals, compared to those without past cataract surgery. Further studies are need-
ed to conclude whether a synergistic effect exists.
The strengths of our study lie in the large number of individuals analyzed. As a population-
based study, selection bias associated with hospital-based studies is minimized. However, our
study is limited by the small number of patients with late AMD, precluding sufficient statistical
power in this group. There may be potential residual confounding by a range of factors includ-
ing amount of sun exposure and type of IOL implant used in the pseudophakic group, although
none of these have been shown to be definitively associated with AMD. In addition, the differ-
ences in MAF of rs10801555 between Malays and Indians could potentially be a source of con-
founding, although this may have been accounted for to a certain extent by the use of principal
components in our multivariate model. As with all cross-sectional observational studies, the
lack of data on the temporal sequence of AMD development after cataract surgery hindered us
from assessing causal relationships. Although we did not find significant differences in visual
acuity between pseudophakic patients with or without early/any AMD who have at least 1
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CFH risk allele, we did not have data on contrast sensitivity, which is more likely (than visual
acuity) to be affected in patients with early stages of AMD. In addition, early AMD is a known
risk factor for late AMD, which has significant impact on visual acuity. In view of these limita-
tions, the clinical relevance of our findings is uncertain at this point in time but as the first
study of its kind, our study provides a basis for future longitudinal cohort studies, to assess this
synergistic effect, which, as discussed above, has potentially clinically significant applications.
In summary, based on our population-based studies, there is a possible synergistic interac-
tion between CFH risk genotypes and lens status. Pseudophakic/aphakic eyes may have an in-
creased risk of early AMD in patients with CFH risk genotypes over and above the risk
conferred by either factor alone. Further longitudinal studies are needed to determine if the
synergistic interaction between CFH risk genotypes and cataract surgery results in a higher in-
cidence of AMD. Further research may be undertaken in IOL biocompatibility and other po-
tential mechanisms to minimize complement activation in the eye after cataract surgery.
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